期刊文献+

靶向结肠癌肿瘤干细胞的结肠癌治疗研究进展 被引量:7

原文传递
导出
摘要 近些年肿瘤干细胞逐渐成为肿瘤研究中的热点,根据2006年美国癌症研究协会给出的定义,肿瘤中具有自我更新能力并能产生异质性肿瘤细胞的细胞被称为肿瘤干细胞。肿瘤干细胞在肿瘤的发生、发展、复发以及转移的过程中均起到决定性的作用。传统的治疗方式只能减小肿瘤的体积、杀伤肿瘤中的分化细胞,而肿瘤干细胞能够抵抗放化疗,最终导致肿瘤复发。
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第11期2472-2473,共2页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金青年基金资助项目(81201688)
  • 相关文献

参考文献21

  • 1Clarke MF,Dick JE,Dirks PB,et al.Cancerstem cells-perspectives on current statusand future directions:AACR Workshop oncancer stem cells.Cancer Res,2006,66:9339-9344. 被引量:1
  • 2O'Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of ini-tiating tumour growth in immunodeficientmice.Nature,2007,445:106-110. 被引量:1
  • 3Dalerba P,Dylla SJ,Park IK,et al.Pheno-typic characterization of human colorectalcancer stem cells.Proc Natl Acad Sci U SA,2007,104:10158-10163. 被引量:1
  • 4冷政伟,尹碧辉,李勇,谭俊,岳中屹,陈锦皇,奚海林,夏清华.悬浮培养结肠癌细胞球具有上皮间质转化特征[J].中华实验外科杂志,2013,30(3):464-467. 被引量:5
  • 5Todaro M,Alea MP,Di Stefano AB,etal.Colon cancer stem cells dictate tumorgrowth and resist cell death by productionof interleukin-4.Cell Stem Cell,2007,1:389402. 被引量:1
  • 6Cammareri P,Scopelliti A,Todaro M,etal.Aurora-a is essential for the tumorigen-ic capacity and chemoresistance of color-ectal cancer stem cells.Cancer Res,2010,70:46554665. 被引量:1
  • 7刘忠,史华俊,朱林波.乳腺癌干细胞的靶向治疗进展[J].中华实验外科杂志,2012,29(7):1414-1416. 被引量:3
  • 8He B,Barg RN5You L,et al.Wnt signa-ling in stem cells and non-small-cell lungcancer.Clin Lung Cancer,2005,7:54-60. 被引量:1
  • 9Nathke IS.The adenomatous polyposis coliprotein:the achilles heel of the gut epithe-lium.Annu Rev Cell Dev Biol,2004,20:337-366. 被引量:1
  • 10van de Wetering M,Sancho E,Verweij C,et al.The beta-catenin/TCF-4 compleximposes a crypt progenitor phenotype oncolorectal cancer cells.Cell,2002,111:241-250. 被引量:1

二级参考文献48

  • 1李治,黄韬,贺艳丽,张家华,张景辉,田元.乳腺癌干细胞逃逸化疗机制的研究[J].中华实验外科杂志,2007,24(1):20-21. 被引量:20
  • 2Visvader JE, Lindeman GJ. Cancer stern cells in solid tumours: accunmtating evi- dence and unresolved questions. Nat Roy Cancer, 2008,8 : 755-768. 被引量:1
  • 3AI-Hajj M, Wicha MS, Benito Hernandez A,et al. Prospective identification of tu- morigenic breast cancer cells. Proc Natl Acad Sci U S A ,2003,100:3983-3988. 被引量:1
  • 4Morrisnn BJ, Schmidt CW, Lakhani SR, et M. Breast cancer stem cells: implications for therapy of b~ast cancer. Breast Cancer Res ,2008,10:210. 被引量:1
  • 5Ginestier C, Hur MH,Charafe-Jauffre! E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinie',d outcome. Cell Stern Cell ,2007,1:555-567. 被引量:1
  • 6Magnifico A, Albano L, Campaner S, et al. Tumour-initiating cells of HER2-posi- tive carcinoma cell lines express the high- est oncoprotein levels and are trasluzmnabsensitive. Clin Cancer Res, 2009, 15: 2010-2021. 被引量:1
  • 7Korkaya H, Paulson A, Iovino F, et al. HER2 regulates the mammary stem/pro- genitor cell population driving tumorigene- sis and invasion. Oncogene, 2008, 27: 6120-6130. 被引量:1
  • 8Jones KL,Buzdar AU. Evolving novel anti- HER2 strategies. Lancet Oncol,2009,10 : 1179-1187. 被引量:1
  • 9Sheridan C, Kishimoto H, Fuchs RK, et al. CD44 +/CD24- breast cancer calls exhibit enhanced invasive properties:an early step necessary for metastasis. Breast Cancer Res 2006,8 : R59. 被引量:1
  • 10Balic M,Lin H,Young L,et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast-cancer stem cell phenotype. Clin Cancer Res, 2006, 12: 5615-5621. 被引量:1

共引文献6

同被引文献74

引证文献7

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部